US 11046752
Serpin fusion polypeptides and methods of use thereof
granted A61KA61K38/00
Quick answer
US patent 11046752 (Serpin fusion polypeptides and methods of use thereof) held by Inhibrx, Inc. expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inhibrx, Inc.
- Grant date
- Tue Jun 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K38/00